<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2587-7836-2020-3-40-47</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-257</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ ФАРМАКОДИНАМИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRECLINICAL PHARMACODYNAMICS STUDIES</subject></subj-group></article-categories><title-group><article-title>Сравнительное изучение нейропротекторной  активности соединений лития и их влияния  на течение экспериментального аллоксанового  сахарного диабета у крыс</article-title><trans-title-group xml:lang="en"><trans-title>Comparative study of the neuroprotective activity of lithium compounds and their effect on the course of experimental  alloxan diabetes mellitus in rats</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2446-6089</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назаренко</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarenko</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Назаренко Ольга Анатольевна, к. м. н., доцент кафедры фармакологии</p></bio><bio xml:lang="en"><p>Nazarenko Olga A. , PhD in Medicine, associate Professor of the Department of Pharmacology</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1064-8201</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демидов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Demidov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Демидов Вадим Игоревич, к. м. н., доцент, заведующий кафедрой патологической анатомии</p></bio><bio xml:lang="en"><p>Demidov Vadim I., PhD in Medicine, associate Professor, Head of the Department of Pathological Anatomy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна, д. м. н, профессор, в. н. с., научный руководитель Института фармакоинформатики при  SPIN-код: 6317-9833</p></bio><bio xml:lang="en"><p>Gromova Olga A., Dr. Sci. (Med.), ProfessorSPIN code: 6317-9833</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5265-6974</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алексахина</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Aleksakhina</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексахина Елена Львовна, к. х. н., доцент кафедры химии, физики, математикиSPIN-код: 2568-6370</p></bio><bio xml:lang="en"><p>Aleksakhina Elena L.,  Candidate of Chemical Sciences, associate Professor of the Department of Chemistry, Physics, MathematicsSPIN code: 2568-6370</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич, к. х. н., с. н. с. SPIN-код: 1375-1114</p></bio><bio xml:lang="en"><p>Torshin Ivan Yu. , Candidate of Chemical Sciences, Senior researcherSPIN code: 1375-1114</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановская государственная медицинская академия» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBEI HE IvSMA MOН Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГУ «Федеральный исследовательский центр «Информатика и управление» Российской академии наук»; Центр хранения и анализа больших данных ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center "Computer Science and Control" of the Russian Academy of Sciences; Big Data Storage and Analysis Center FSEI HPE Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>06</month><year>2021</year></pub-date><volume>0</volume><issue>3</issue><fpage>40</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Назаренко О.А., Демидов В.И., Громова О.А., Алексахина Е.Л., Торшин И.Ю., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Назаренко О.А., Демидов В.И., Громова О.А., Алексахина Е.Л., Торшин И.Ю.</copyright-holder><copyright-holder xml:lang="en">Nazarenko O.A., Demidov V.I., Gromova O.A., Aleksakhina E.L., Torshin I.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/257">https://www.pharmacokinetica.ru/jour/article/view/257</self-uri><abstract><p>Проведено сравнительное исследование эффектов неорганической соли лития (карбоната лития) и органической соли лития (аскорбат лития) на модели аллоксанового сахарного диабета. Применение аскорбата лития в течение месяца при экспериментальном аллоксановом сахарном диабете облегчает его течение – повышается выживаемость животных, снижается уровень гликемии (особенно при введении в дозе 10 мг/кг).Морфометрический анализ показал, что аскорбат лития при аллоксановом диабете оказывает нейропротекторное действие, что проявляется в уменьшении токсического повреждения нейроцитов с увеличением количества клеток с обратимыми изменениями и неповреждённых нейронов. Карбонат лития в дозах 5 и 10 мг/кг не был эффективен.</p></abstract><trans-abstract xml:lang="en"><p>A comparative study of the effects of an inorganic lithium salt (lithium carbonate) and an organic lithium salt (lithium ascorbate) on a model of alloxan diabetes mellitus was conducted. The use of lithium ascorbate for a month in experimental alloxan diabetes mellitus facilitates its course – the survival rate of animals increases, the level of glycemia decreases (especially when administered at a dose of 10 mg/kg). Morphometric analysis showed that lithium ascorbate in alloxan diabetes has a neuroprotective effect, which is manifested in a decrease in toxic damage to neurocytes with an increase in the number of cells with reversible changes and intact neurons. Lithium carbonate at doses of 5 and 10 mg / kg was not effective.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>карбонат лития</kwd><kwd>аскорбат лития</kwd><kwd>аллоксановый сахарный диабет</kwd><kwd>крысы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lithium carbonate</kwd><kwd>lithium ascorbate</kwd><kwd>alloxan diabetes mellitus</kwd><kwd>rats</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">ВОЗ. Глобальный доклад по диабету. [Электронный ресурс]. Доступно по: http://www.who.int/diabetes/global-report/ru/ Ссылка активна на 23.12.2020.</mixed-citation><mixed-citation xml:lang="en">WHO. Global report on diabetes. [Electronic resource]. (In Russ).Доступно по: http://www.who.int/diabetes/global-report/ru/ Ссылка активна на 23.12.2020.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Siddiqui K, Bawazeer N, Joy SS. Variation in macro and trace elements in progression of type 2 diabetes. ScientificWorldJournal.2014;2014:461591. DOI: 10.1155/2014/461591.</mixed-citation><mixed-citation xml:lang="en">Siddiqui K, Bawazeer N, Joy SS. Variation in macro and trace elements in progression of type 2 diabetes. ScientificWorldJournal.2014;2014:461591. DOI: 10.1155/2014/461591.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Squassina A, Costa M, Congiu D et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res.2013 Jul;73:1–7. DOI: 10.1016/j.phrs.2013.04.004.</mixed-citation><mixed-citation xml:lang="en">Squassina A, Costa M, Congiu D et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res.2013 Jul;73:1–7. DOI: 10.1016/j.phrs.2013.04.004.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zawalich WS, Zawalich KC, Rasmussen H. Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perfused rat islets. Biochem J.1989;262(2):557–561. DOI: 10.1042/bj2620557.</mixed-citation><mixed-citation xml:lang="en">Zawalich WS, Zawalich KC, Rasmussen H. Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perfused rat islets. Biochem J.1989;262(2):557–561. DOI: 10.1042/bj2620557.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Diaz-Sastre C, Perez-Rodriguez MM, Cebollada A et al. Cholesterol and lithium levels were correlated but serum HDL and total cholesterol levels were not associated with current mood state in bipolar patients. J Clin Psychiatry. 2005;66(3):399-400. DOI: 10.4088/jcp.v66n0318i.</mixed-citation><mixed-citation xml:lang="en">Diaz-Sastre C, Perez-Rodriguez MM, Cebollada A et al. Cholesterol and lithium levels were correlated but serum HDL and total cholesterol levels were not associated with current mood state in bipolar patients. J Clin Psychiatry. 2005;66(3):399-400. DOI: 10.4088/jcp.v66n0318i.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lijnen P, Bex M, Bouillon R et al. Erythrocyte sodium-lithium countertransport in insulin-dependent diabetics: correlation with membrane lipids, prorenin and micro-albuminuria. J Hypertens Suppl. 1993;11(5):S258–259.</mixed-citation><mixed-citation xml:lang="en">Lijnen P, Bex M, Bouillon R et al. Erythrocyte sodium-lithium countertransport in insulin-dependent diabetics: correlation with membrane lipids, prorenin and micro-albuminuria. J Hypertens Suppl. 1993;11(5):S258–259.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zawalich WS, Zawalich KC, Rasmussen H. Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perifused rat islets. Biochem J.1989;262(2):557–561. DOI: 10.1042/bj2620557.</mixed-citation><mixed-citation xml:lang="en">Zawalich WS, Zawalich KC, Rasmussen H. Interactions between lithium, inositol and mono-oleoylglycerol in the regulation of insulin secretion from isolated perifused rat islets. Biochem J.1989;262(2):557–561. DOI: 10.1042/bj2620557.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Macko AR, Beneze AN, Teachey MK, Henriksen EJ. Roles of insulin signalling and p38 MAPK in the activation by lithium of glucose transport in insulin-resistant rat skeletal muscle. Arch Physiol Biochem. 2008;114(5):331–339. DOI: 10.1080/13813450802536067.</mixed-citation><mixed-citation xml:lang="en">Macko AR, Beneze AN, Teachey MK, Henriksen EJ. Roles of insulin signalling and p38 MAPK in the activation by lithium of glucose transport in insulin-resistant rat skeletal muscle. Arch Physiol Biochem. 2008;114(5):331–339. DOI: 10.1080/13813450802536067.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cimarosti H, Rodnight R, Tavares A et al. An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation. Neurosci Lett. 2001;315(1-2):33–36. DOI: 10.1016/s0304-3940(01)02310-2.</mixed-citation><mixed-citation xml:lang="en">Cimarosti H, Rodnight R, Tavares A et al. An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation. Neurosci Lett. 2001;315(1-2):33–36. DOI: 10.1016/s0304-3940(01)02310-2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Гоголева И.В. Влияние органических солей лития, магния, селена на элементный гомеостаз головного мозга на фоне экспериментальной хронической окклюзии общих сонных артерий: Автореф. дис... канд. мед. наук. — Москва; 2009.</mixed-citation><mixed-citation xml:lang="en">Gogoleva IV. Vliyanie organicheskih solej litiya, magniya, selena na elementnyj gomeostaz golovnogo mozga na fone eksperimental'noj hronicheskoj okklyuzii obshchih sonnyh arterij. [dissertation] Moscow; 2009. (In Russ).] Доступно по: https://www.dissercat.com/content/vliyanie-organicheskikh-solei-litiyamagniya-selena-na-elementnyi-gomeostaz-golovnogo-mozga- Ссылка активна на 23.12.2020.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sinha D, Wang Z, Ruchalski KL et al. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol.2005;288(4):F703–13. DOI: 10.1152/ajprenal.00189.2004.</mixed-citation><mixed-citation xml:lang="en">Sinha D, Wang Z, Ruchalski KL et al. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol.2005;288(4):F703–13. DOI: 10.1152/ajprenal.00189.2004.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ребров В.Г. Витамины, макро- и микроэлементы / Ребров В.Г., Громова О.А. – М.: ГЭОТАР-Медиа; 2008. 960 с.</mixed-citation><mixed-citation xml:lang="en">Rebrov VG. Vitaminy, makro- i mikroelementy / Rebrov VG, Gromova OA. Moscow: GEOTARMedia; 2008. (In Russ). ISBN 978-5-9704-0814-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
